Children and adolescents with obesity and insulin resistance have elevated concentrations of fasting plasma glucagon and GLP-1, elevated glucagon, and attenuated GLP-1 responses during the OGTT, which is paralleled by lower estimates of insulin sensitivity and altered β-cell function. The gene discussed is INS; the disease is Obesity.